PEP Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer.
Tag Archives: protein-protein interactions
Sygnis – innovative polymerases
Sygnis is a biotech company developing innovative tools for molecular biology that play key roles in changing the way genomic and proteomic research is done today.
Sygnis – innovative polymerases
iProteos – peptidomimetics experts
iProteos focuses its activity on developing new therapeutic strategies based on modulation of protein-protein interactions (PPIs) or protein-ligand interactions (PLI). Specifically, iProteos apply the IPRO technology to search for therapeutic agents treating diseases of the central nervous system (CNS). Based on its expertise, iProteos would be your perfect partner for the discovery of potent and active peptidomimetics for your own targets.
iProteos – peptidomimetics experts
